India's medical tourism industry is in a quiet downturn. Foreign patient arrivals have fallen roughly a third since 2019 from nearly 700,000 visitors to around 500,000 dragged down by strained ties with Bangladesh, visa processing times stretching up to 60 days, and aggressive competition from Thailand, Malaysia, and Singapore. A tax incidence on medical referrals threatens to push costs higher just as global insurers remain largely unempanelled with Indian hospitals. The silver lining: average revenue per patient is rising, as high-value procedures like oncology and cardiac surgery now dominate. Host Anirban Chowdhury talks to ET’s Forum Gandhi and pharma editor Vikas Dandekar about the problem, its reasons and fixes.

Listen in:

You can follow Anirban Chowdhury on his social media: X and Linkedin

Check out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks and much more.

Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

See omnystudio.com/listener for privacy information.

India's Medical Tourism Slips Off the Table